Comparing the Differences in Adverse Events among Chimeric Antigen Receptor T-Cell Therapies: A Real-World Pharmacovigilance Study

• Váldodahkkit: Zihan Guo (Dahkki), Yunlan Ding (Dahkki), Mengmeng Wang (Dahkki), Qing Zhai (Dahkki), Jiyong Liu (Dahkki), Qiong Du (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: MDPI AG, 2024-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

In this study, we compared the similarities and differences in adverse events (AEs) among CAR T-cell products through signal mining via the FDA Adverse Event Reporting System (FAERS) and identified unknown AEs to provide a reference for safe clinical medication. Data from the FAERS database spanning...